<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=N-end_rule</id>
	<title>N-end rule - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=N-end_rule"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=N-end_rule&amp;action=history"/>
	<updated>2026-04-26T22:26:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=N-end_rule&amp;diff=5456562&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=N-end_rule&amp;diff=5456562&amp;oldid=prev"/>
		<updated>2024-03-27T04:51:21Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;N-end rule&amp;#039;&amp;#039;&amp;#039; refers to a cellular rule that relates the [[half-life]] of a [[protein]] to the identity of its N-terminal [[amino acid]]. This rule is a part of the [[ubiquitin-proteasome system]], which is responsible for [[protein degradation]] within [[cell]]s. The N-end rule pathway is a subset of the ubiquitin system and plays a crucial role in [[protein quality control]], [[signal transduction]], and the regulation of various physiological processes.&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The N-end rule pathway was first described in the 1980s by Alexander Varshavsky and colleagues. It posits that the [[stability]] and function of a protein can be influenced by the amino acid located at the N-terminus (the beginning) of the protein. Certain N-terminal amino acids can render a protein more stable, while others can mark the protein for rapid degradation via the ubiquitin-proteasome system.&lt;br /&gt;
&lt;br /&gt;
==Mechanism==&lt;br /&gt;
The N-end rule pathway involves three main components: recognition components, conjugation components, and proteolytic components. Recognition components identify proteins that contain destabilizing N-terminal residues. Conjugation components attach [[ubiquitin]] molecules to these proteins, marking them for degradation. Finally, proteolytic components, mainly the 26S [[proteasome]], recognize and degrade the ubiquitinated proteins.&lt;br /&gt;
&lt;br /&gt;
The specificity of the N-end rule pathway is determined by the type of N-terminal amino acid. Basic amino acids (e.g., arginine, lysine, and histidine), bulky hydrophobic amino acids (e.g., phenylalanine, tryptophan, and tyrosine), and certain other residues are recognized as destabilizing, leading to the protein&amp;#039;s rapid degradation. Conversely, stabilizing amino acids (e.g., methionine, alanine, valine, and serine) can confer longer half-lives to proteins.&lt;br /&gt;
&lt;br /&gt;
==Physiological Roles==&lt;br /&gt;
The N-end rule pathway has been implicated in a wide range of cellular processes, including the regulation of [[gene expression]], the timing of [[cell cycle]] events, [[apoptosis]], and responses to [[stress]] and [[nutrient availability]]. It also plays a role in the targeting of misfolded or damaged proteins for degradation, thus maintaining [[protein homeostasis]] within the cell.&lt;br /&gt;
&lt;br /&gt;
==Evolutionary Significance==&lt;br /&gt;
The N-end rule pathway is evolutionarily conserved across all kingdoms of life, from [[yeast]] to [[mammals]], highlighting its fundamental importance in cellular biology. This conservation suggests that the ability to regulate protein stability and function via the N-terminal amino acid is a critical evolutionary adaptation.&lt;br /&gt;
&lt;br /&gt;
==Research and Applications==&lt;br /&gt;
Research into the N-end rule pathway has potential applications in [[biotechnology]] and [[medicine]]. For example, manipulating the N-end rule pathway could be used to control the degradation rate of specific proteins, with implications for the treatment of diseases characterized by abnormal protein accumulation or degradation, such as [[neurodegenerative diseases]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Cell biology]]&lt;br /&gt;
[[Category:Protein degradation]]&lt;br /&gt;
{{stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>